Ulrike E. Hille

521 total citations
16 papers, 433 citations indexed

About

Ulrike E. Hille is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrike E. Hille has authored 16 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrike E. Hille's work include Estrogen and related hormone effects (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Hormonal Regulation and Hypertension (5 papers). Ulrike E. Hille is often cited by papers focused on Estrogen and related hormone effects (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Hormonal Regulation and Hypertension (5 papers). Ulrike E. Hille collaborates with scholars based in Germany, Italy and United States. Ulrike E. Hille's co-authors include Rolf W. Hartmann, Qingzhong Hu, Carsten Jagusch, Carsten A. Vock, Christina Zimmer, Matthias Negri, Ursula Müller‐Vieira, Thomas Lauterbach, Jörg Haupenthal and Marc Bartels and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Ulrike E. Hille

13 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike E. Hille Germany 11 200 148 129 105 104 16 433
Takenori Hitaka Japan 10 133 0.7× 51 0.3× 103 0.8× 92 0.9× 137 1.3× 15 434
Diana Ayán Canada 11 112 0.6× 32 0.2× 157 1.2× 64 0.6× 105 1.0× 23 302
Ivonne Heuze Mexico 14 177 0.9× 25 0.2× 134 1.0× 51 0.5× 184 1.8× 28 391
Irina Grabovec Belarus 8 107 0.5× 169 1.1× 50 0.4× 14 0.1× 200 1.9× 17 409
Elyse M. Petrunak United States 12 101 0.5× 136 0.9× 77 0.6× 57 0.5× 179 1.7× 14 393
Robert I. Higuchi United States 11 143 0.7× 27 0.2× 164 1.3× 218 2.1× 148 1.4× 18 446
James C. Lanter United States 18 93 0.5× 25 0.2× 49 0.4× 392 3.7× 180 1.7× 34 584
Harold E. Osborne United States 9 54 0.3× 23 0.2× 168 1.3× 69 0.7× 217 2.1× 11 455
Akifumi Kogame Japan 9 129 0.6× 38 0.3× 57 0.4× 24 0.2× 186 1.8× 14 380
Patricia Kruchten Germany 12 395 2.0× 81 0.5× 414 3.2× 205 2.0× 184 1.8× 13 621

Countries citing papers authored by Ulrike E. Hille

Since Specialization
Citations

This map shows the geographic impact of Ulrike E. Hille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike E. Hille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike E. Hille more than expected).

Fields of papers citing papers by Ulrike E. Hille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike E. Hille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike E. Hille. The network helps show where Ulrike E. Hille may publish in the future.

Co-authorship network of co-authors of Ulrike E. Hille

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike E. Hille. A scholar is included among the top collaborators of Ulrike E. Hille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike E. Hille. Ulrike E. Hille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hille, Ulrike E., Philipp Soergel, Liza Makowski, Thilo Dörk, & Peter Hillemanns. (2012). Lymphedema of the Breast as a Symptom of Internal Diseases or Side Effect of mTor Inhibitors. Lymphatic Research and Biology. 10(2). 63–73. 10 indexed citations
2.
Hille, Ulrike E., Matthias Jentschke, Philipp Soergel, et al.. (2012). Erste Erfahrungen mit azellulärer porciner dermaler Matrix in der rekonstruktiven Brustchirurgie mit Implantaten. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 9(2). 106–110. 1 indexed citations
3.
Hille, Ulrike E., Christina Zimmer, Jörg Haupenthal, & Rolf W. Hartmann. (2011). Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases. ACS Medicinal Chemistry Letters. 2(8). 559–564. 33 indexed citations
4.
Wojcinski, Sebastian, et al.. (2011). The Automated Breast Volume Scanner (ABVS): Initial Experiences in Lesion Detection and Interobserver Concordance of a New Method. Ultrasound in Medicine & Biology. 37(8). S46–S47.
5.
Hu, Qingzhong, Carsten Jagusch, Ulrike E. Hille, Jörg Haupenthal, & Rolf W. Hartmann. (2010). Replacement of Imidazolyl by Pyridyl in Biphenylmethylenes Results in Selective CYP17 and Dual CYP17/CYP11B1 Inhibitors for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 53(15). 5749–5758. 46 indexed citations
6.
Steiert, Andreas, Ulrike E. Hille, William F. Burke, et al.. (2010). Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations. Journal of Plastic Reconstructive & Aesthetic Surgery. 64(2). 240–247. 18 indexed citations
7.
Hu, Qingzhong, Lina Yin, Carsten Jagusch, Ulrike E. Hille, & Rolf W. Hartmann. (2010). Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors. Journal of Medicinal Chemistry. 53(13). 5049–5053. 65 indexed citations
8.
Hille, Ulrike E., Christina Zimmer, Carsten A. Vock, & Rolf W. Hartmann. (2010). First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases. ACS Medicinal Chemistry Letters. 2(1). 2–6. 63 indexed citations
9.
Hille, Ulrike E., Qingzhong Hu, Marc Bartels, et al.. (2009). Steroidogenic cytochrome P450 (CYP) enzymes as drug targets: Combining substructures of known CYP inhibitors leads to compounds with different inhibitory profile. Comptes Rendus Chimie. 12(10-11). 1117–1126. 20 indexed citations
10.
Hille, Ulrike E., Qingzhong Hu, Carsten A. Vock, et al.. (2009). Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls. European Journal of Medicinal Chemistry. 44(7). 2765–2775. 57 indexed citations
11.
Negri, Matthias, Qingzhong Hu, Ulrike E. Hille, et al.. (2008). CYP17 Inhibitors. Annulations of Additional Rings in Methylene Imidazole Substituted Biphenyls: Synthesis, Biological Evaluation and Molecular Modelling. Archiv der Pharmazie. 341(10). 597–609. 21 indexed citations
12.
13.
Negri, Matthias, Carsten Jagusch, Ulrike E. Hille, et al.. (2007). Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17. Bioorganic & Medicinal Chemistry Letters. 18(1). 267–273. 24 indexed citations
14.
Kuschinsky, G., et al.. (1952). Über die Wirkung von Adrenochrom an isolierten Organen. PubMed. 215(1-2). 39–47.
15.
Kuschinsky, G., Ulrike E. Hille, & H. Schimassek. (1952). Über Histamin als Mittler-Substanz bei der Wirkung von Adrenochrom auf die Blutungszeit. PubMed. 215(1-2). 48–51. 1 indexed citations
16.
Kuschinsky, G., et al.. (1952). �ber die Freisetzung von Histamin durch Adrenochrom. Journal of Molecular Medicine. 30(17-18). 420–421.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takenori Hitaka Breakdown of academic impact, for papers by Diana Ayán Breakdown of academic impact, for papers by Ivonne Heuze Breakdown of academic impact, for papers by Irina Grabovec Breakdown of academic impact, for papers by Elyse M. Petrunak Breakdown of academic impact, for papers by Robert I. Higuchi Breakdown of academic impact, for papers by James C. Lanter Breakdown of academic impact, for papers by Harold E. Osborne Breakdown of academic impact, for papers by Akifumi Kogame Breakdown of academic impact, for papers by Patricia Kruchten
Rankless by CCL
2026